Skip to main content
. Author manuscript; available in PMC: 2024 Jan 7.
Published in final edited form as: Cancer Discov. 2023 Jul 7;13(7):1678–1695. doi: 10.1158/2159-8290.CD-22-1013

Figure 6.

Figure 6.

SRSF1 increases IL1R1 expression through alternative splicing, contributing to pancreatitis and transformation. A, Venn diagram of genes upregulated in SC and KSC organoids treated with Dox versus untreated; and genes downregulated in KSC organoids compared to SC organoids, both without Dox treatment. B, Real-time PCR validation of Il1r1 expression changes in SC and KSC organoids treated with Dox (n = 3 biological replicates). One-way ANOVA with Tukey’s multiple comparison test. *p <0.05, ***p <0.001. Error bars represent mean ± SD. C, Volcano plots of splicing changes in MAPK signaling pathway-associated genes from SC and KSC organoids treated with Dox. D, Scheme and radioactive RT–PCR of SRSF1-regulated splicing event in Il1r1 pre-mRNA from SC and KSC organoids treated with Dox. The percent spliced in (PSI) was quantified for each condition (right, n = 3 biological replicates). One-way ANOVA with Tukey’s multiple comparison test. ***p <0.001. Error bars represent mean ± SD. E, Radioactive RT–PCR of SRSF1-regulated splicing event in Il1r1 pre-mRNA from Dox-inducible T7-SRSF1-expressing HPDE cells and human normal pancreatic hN40 organoids treated with Dox. The percent spliced in (PSI) was quantified for each condition (top panel, n = 3 biological replicates). Unpaired two-tailed t test. ***p <0.001. Error bars represent mean ± SD. F, Diagram of Il1r1 minigene. Mutations were introduced to disrupt SRSF1 binding motif(s). G, Radioactive RT-PCR results of Il1r1 minigene assays (top left), and Western blotting of T7-tag (bottom left) in 293T cells overexpressing T7-SRSF1. The percentage of exon 3 inclusion was quantified for each condition (right, n = 3 biological replicates). One-way ANOVA with Tukey’s multiple comparison test. ***p <0.001. Error bars represent mean ± SD. H, IHC staining of IL1R1 in pancreas tissues from SC mice with Dox treatment for 3 days (n = 5 per group). Scale bars, 50 μm. I, Western blotting of IL1R1, endogenous and T7-tagged SRSF1 in SC organoids treated with Dox. J, mRNA-decay assay of the Il1r1 isoforms in SC organoids harvested at the indicated times after actinomycin D treatment. mRNAs were quantified by real-time PCR, normalized to Gapdh levels, and expressed as a percentage of the levels at time 0 h (n = 3 biological replicates). K, HE staining of pancreata of SC and SCIl1r1Δ/Δ mice with Dox treatment (n = 5 per group). Scale bars, 50 μm. The affected area was quantified on the right. Statistical analysis was performed by a linear mixed-effects model with the experimental group, time, and group by time interaction as fixed effects, and the sample-specific random intercept was used to estimate the % affected area.